Sustainable Agro Solutions announces the acquisition of Biovert

Stirling Square Capital Partners (″Stirling Square″), a leading pan-European mid-market private equity firm, announces that its portfolio company Sustainable Agro Solutions (″SAS″), a leading developer and producer of bio-stimulants, soil and water improvers, defence activators and specialty plant nutrition solutions for the agricultural sector, has acquired Biovert, a developer and producer of bio-stimulants, biocontrol and specialty plant nutrition solutions for the agricultural sector. Financial terms of the transaction have not been disclosed.

Stirling Square will support SAS and Biovert to consolidate their leadership position in the fragmented biosolutions market, both organically (through R&D investments, product development and expansion into new geographic markets) and through M&A.

Founded in 1988, Biovert is a family-owned developer and producer of bio-stimulants, biocontrol and other specialty plant nutrition solutions (including soil correctors, protectors) for the agricultural sector, with strong in-house R&D capabilities. Biovert is based, like SAS, in Lleida, a key agronomic hub in Southern Europe, with a robust international profile particularly in Latin America and northern Africa.

Eduard Vallverdú, CEO of SAS, said: ″We are pleased to announce the acquisition of Biovert, a business that is close to ours, having a culture that that is aligned to SAS’ and complementary technologies. Biovert has a high-quality product portfolio, a strong knowledge of the bio-stimulants sector, including seaweed extracts – a strategic growth area for our business – as well as a leading position in organic solutions. Biovert has an experienced and committed management team, who has executed on a clear strategic vision and has promoted a culture based on innovation and excellence. I am looking forward to seeing both teams work together to reinforce our long term strategy. Stirling Square has been instrumental in supporting this transformational investment which will help achieve the next phase of our growth strategy.″

Enric Bonet, CEO of Biovert, added: ″This is an important step in our growth journey, and I am delighted Biovert is combining with SAS who share our heritage and vision, both underpinned by a commitment to R&D and innovation, as well as a common interest in internationalisation″.

‍Enrico Biale, Partner at Stirling Square, commented: ″We are thrilled to announce the acquisition of Biovert, in line with our strategy of supporting SAS’s growth both organically and through selected acquisitions. The strong cultural fit between teams, as well as the complementary nature of Biovert’s business – geographically and from a product technology perspective – make this the ideal first acquisition for SAS. This is an important step forward in our ambition to jointly create one of the global leaders in the development and production of biosolutions″.

Stirling Square acquired a majority stake in SAS in July 2021. The Firm has extensive experience investing alongside family-owned businesses across Europe.

Join us to show your expertise in the coming issue!

Contact: joyce@agropages.com